| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Molecular Pathology Program, Centre dInvestigacions en Bioquímica i Biologia Molecular (CIBBIM), Barcelona 08035, Spain [A. M., H. A., S. S.]; Servei de Cirurgia General, Hospital General Universitari Vall dHebron, Barcelona 08035, Spain [E. E., M. A.]; and First Department of Internal Medicine, Sapporo Medical University, Sapporo 060-8543, Japan [H. Y.]
Maintenance of genomic stability depends on the appropriate cellular responses to DNA damage and the integrity of the DNA repair systems. We analyzed stomach tumors with microsatellite instability (MSI) for frameshift mutations in several potential targets of the mutator phenotype involved in DNA damage-response pathways, such as the ataxia telangiectasia mutated protein-related protein (ATR)-CHK1-Cdc25c pathway, and DNA repair. High frequency of mutations was found within ATR [5 (21%) of 23], MED1 [10 (43%) of 23], hMSH3 [13 (56%) of 23], and hMSH6 [10 (43%) of 23] genes. Also, a low frequency of mutations within the CHK1 gene was detected in 9% (2 of 23) of tumors. No mutations of hMLH3, ATM, BRCA1, or NBS1 genes were detected. These results confirm ATR, MED1, and CHK1 as targets of the mutator pathway in stomach tumorigenesis, and also suggest a potential role of MED1 increasing, together with hMSH3 and hMSH6, the genomic instability in the mutator pathway as a secondary mutator. Furthermore, these results suggest that the inhibition of the ATR-CHK1 DNA damage-response pathway might be involved in the tumorigenesis of gastric cancer with microsatellite instability.
This article has been cited by other articles:
![]() |
J. Wang, Q. Gu, M. Li, W. Zhang, M. Yang, B. Zou, S. Chan, L. Qiao, B. Jiang, S. Tu, et al. Identification of XAF1 as a novel cell cycle regulator through modulating G2/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer Carcinogenesis, September 1, 2009; 30(9): 1507 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Jardim, Q. Wang, R. Furumai, T. Wakeman, B. K. Goodman, and X.-F. Wang Reduced ATR or Chk1 Expression Leads to Chromosome Instability and Chemosensitization of Mismatch Repair-deficient Colorectal Cancer Cells Mol. Biol. Cell, September 1, 2009; 20(17): 3801 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zighelboim, A. P. Schmidt, F. Gao, P. H. Thaker, M. A. Powell, J. S. Rader, R. K. Gibb, D. G. Mutch, and P. J. Goodfellow ATR Mutation in Endometrioid Endometrial Cancer Is Associated With Poor Clinical Outcomes J. Clin. Oncol., July 1, 2009; 27(19): 3091 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, A. Niimi, S. Limsirichaikul, S. Tomida, Q. Miao Huang, S. Izuta, J. Usukura, Y. Itoh, T. Hishida, T. Akashi, et al. PCNA Mono-Ubiquitination and Activation of Translesion DNA Polymerases by DNA Polymerase {alpha} J. Biochem., July 1, 2009; 146(1): 13 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lewis, K. K. Lilly, E. A. Reynolds, W. P. Sullivan, S. H. Kaufmann, and W. A. Cliby Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin Mol. Cancer Ther., April 1, 2009; 8(4): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Chanoux, B. Yin, K. A. Urtishak, A. Asare, C. H. Bassing, and E. J. Brown ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress J. Biol. Chem., February 27, 2009; 284(9): 5994 - 6003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Ehlers, L. Worley, M. D. Onken, and J. W. Harbour Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma Clin. Cancer Res., January 1, 2008; 14(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Levitt, M. Zhu, A. Cassano, S. A. Yazinski, H. Liu, J. Darfler, R. M. Peters, and R. S. Weiss Genome Maintenance Defects in Cultured Cells and Mice following Partial Inactivation of the Essential Cell Cycle Checkpoint Gene Hus1 Mol. Cell. Biol., March 15, 2007; 27(6): 2189 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zaugg, Y.-W. Su, P. T. Reilly, Y. Moolani, C. C. Cheung, R. Hakem, A. Hirao, Q. Liu, S. J. Elledge, and T. W. Mak Cross-talk between Chk1 and Chk2 in double-mutant thymocytes PNAS, March 6, 2007; 104(10): 3805 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Freiberg, E. M. Hammond, M. J. Dorie, S. M. Welford, and A. J. Giaccia DNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response. Mol. Cell. Biol., March 1, 2006; 26(5): 1598 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp Tumor suppressor genetics Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lewis, S. Mullany, B. Thomas, J. Chien, R. Loewen, V. Shridhar, and W. A. Cliby Heterozygous ATR Mutations in Mismatch Repair-Deficient Cancer Cells Have Functional Significance Cancer Res., August 15, 2005; 65(16): 7091 - 7095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alazzouzi, E. Domingo, S. Gonzalez, I. Blanco, M. Armengol, E. Espin, A. Plaja, S. Schwartz, G. Capella, and S. Schwartz Jr Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis Hum. Mol. Genet., January 15, 2005; 14(2): 235 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ottini, M. Falchetti, C. Saieva, M. De Marco, G. Masala, I. Zanna, M. Paglierani, G. Giannini, A. Gulino, G. Nesi, et al. MRE11 expression is impaired in gastric cancer with microsatellite instability Carcinogenesis, December 1, 2004; 25(12): 2337 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marinkovic, T. Marinkovic, E. Kokai, T. Barth, P. Moller, and T. Wirth Identification of novel Myc target genes with a potential role in lymphomagenesis Nucleic Acids Res., October 11, 2004; 32(18): 5368 - 5378. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Li, E. I. Shagisultanova, K. Yamashita, Z. Piao, M. Perucho, and S. R. Malkhosyan Hypersensitivity of Tumor Cell Lines with Microsatellite Instability to DNA Double Strand Break Producing Chemotherapeutic Agent Bleomycin Cancer Res., July 15, 2004; 64(14): 4760 - 4767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al. A proteomic study of resistance to deoxycholate-induced apoptosis Carcinogenesis, May 1, 2004; 25(5): 681 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawabe G2 checkpoint abrogators as anticancer drugs Mol. Cancer Ther., April 1, 2004; 3(4): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Tay, S. H. Leong, K. Yu, A. Aggarwal, S. Y. Tan, C. H. Lee, K. Wong, J. Visvanathan, D. Lim, W. K. Wong, et al. A Combined Comparative Genomic Hybridization and Expression Microarray Analysis of Gastric Cancer Reveals Novel Molecular Subtypes Cancer Res., June 15, 2003; 63(12): 3309 - 3316. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |